Posology, Efficacy, and Safety of Epidermal Growth Factor Eye Drops in 305 Patients: Logistic Regression and Group-Wise Odds of Published Data

Faculty Opinions recommendation of Efficacy and safety of anti-epidermal growth factor receptor agents for the treatment of oesophageal cancer: a systematic review and meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739805508.793584158 ◽

2021 ◽

Author(s):

Alexandru Grigorescu

Keyword(s):

Systematic Review ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Oesophageal Cancer ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Efficacy And Safety ◽

Efficacy and safety of nano-silver dressings combined with recombinant human epidermal growth factor for deep second-degree burns: A meta-analysis

Burns ◽

10.1016/j.burns.2019.12.015 ◽

2020 ◽

Author(s):

Siqing Li ◽

Yuan Liu ◽

Zehao Huang ◽

Yan Kou ◽

Ailing Hu

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Efficacy And Safety ◽

Nano Silver ◽

Human Epidermal Growth Factor ◽

Epidermal Growth ◽

Second Degree

Efficacy and safety of bevacizumab in the treatment of human epidermal growth factor receptor type 2 negative metastatic breast cancer: About a large series in moroccan population

Indian Journal of Cancer ◽

10.4103/0019-509x.146779 ◽

2014 ◽

Vol 51 (3) ◽

pp. 272 ◽

Cited By ~ 1

Author(s):

N Majid ◽

S Boutayeb ◽

H Errihani

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Efficacy And Safety ◽

The Efficacy and Safety of Gefitinib in Elderly Patients with Epidermal Growth Factor Receptor Mutation-positive Advanced Non-small Cell Lung Cancer

Haigan ◽

10.2482/haigan.56.177 ◽

2016 ◽

Vol 56 (3) ◽

pp. 177-182

Author(s):

Kei Kusaka ◽

Takashi Hirose ◽

Atsuhisa Tamura ◽

Masahiro Ohgiya ◽

Hirotoshi Matsui ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Elderly Patients ◽

Growth Factor Receptor ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung ◽

A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer

Indian Journal of Cancer ◽

10.4103/ijc.ijc_449_17 ◽

2017 ◽

Vol 54 (4) ◽

pp. 664

Author(s):

Prasad Apsangikar ◽

Sunil Chaudhry ◽

Manoj Naik ◽

Shashank Deoghare ◽

Jamila Joseph

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Phase Iii ◽

Efficacy And Safety ◽

Human Epidermal Growth Factor ◽

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

European Journal of Cancer ◽

10.1016/j.ejca.2018.04.004 ◽

2018 ◽

Vol 97 ◽

pp. 7-15 ◽

Cited By ~ 9

Author(s):

S. Cavalieri ◽

F. Perrone ◽

R. Miceli ◽

P.A. Ascierto ◽

L.D. Locati ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Single Agent ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Efficacy And Safety ◽

Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

JAMA Network Open ◽

10.1001/jamanetworkopen.2019.16211 ◽

2019 ◽

Vol 2 (11) ◽

pp. e1916211 ◽

Cited By ~ 3

Author(s):

Neil M. Iyengar ◽

Lillian M. Smyth ◽

Diana Lake ◽

Ayca Gucalp ◽

Jasmeet C. Singh ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Human Epidermal Growth Factor ◽

Efficacy and safety of neoadjuvant chemotherapy with concurrent liposomal-encapsulated doxorubicin, paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive breast cancer in clinical practice

International Journal of Clinical Oncology ◽

10.1007/s10147-014-0727-x ◽

2014 ◽

Vol 20 (3) ◽

pp. 480-489 ◽

Cited By ~ 4

Author(s):

Joaquín Gavilá ◽

Ángel Guerrero ◽

Miguel Ángel Climent ◽

Aranzazu Fernández ◽

Francisco Gozalbo ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Neoadjuvant Chemotherapy ◽

Growth Factor Receptor ◽

Efficacy And Safety ◽

Epidermal Growth ◽

Positive Breast Cancer

53O_PR Efficacy and safety of palbociclib plus fulvestrant in Asian women with hormone receptor-positive (HR+)/human epidermal growth factor-2 negative (HER2-) metastatic breast cancer (MBC) that progressed on prior endocrine therapy (ET)

Annals of Oncology ◽

10.1093/annonc/mdv519.02 ◽

2015 ◽

Vol 26 ◽

pp. ix16

Author(s):

J. Ro ◽

S.-A. Im ◽

N. Masuda ◽

Y.-H. Im ◽

K. Inoue ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Hormone Receptor ◽

Metastatic Breast ◽

Asian Women ◽

Efficacy And Safety ◽

Hormone Receptor Positive ◽

Meta-analysis: The efficacy and safety of monoclonal antibody targeted to epidermal growth factor receptor in the treatment of patients with metastatic colorectal cancer

Journal of Digestive Diseases ◽

10.1111/j.1751-2980.2009.00393.x ◽

2009 ◽

Vol 10 (4) ◽

pp. 247-257 ◽

Cited By ~ 12

Author(s):

Fang NIE ◽

Jun SHEN ◽

Jin Lu TONG ◽

Xi Tao XU ◽

Ming Ming ZHU ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Efficacy And Safety ◽